Prescription Drug Pricing In The Private Sector

Download Prescription Drug Pricing In The Private Sector full books in PDF, epub, and Kindle. Read online Prescription Drug Pricing In The Private Sector ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!

Prescription Drug Pricing in the Private Sector

Author : Donald Marron
Publisher : CreateSpace
ISBN 13 : 9781470111458
Total Pages : 34 pages
Book Rating : 4.1/5 (114 download)

DOWNLOAD NOW!

Book Synopsis Prescription Drug Pricing in the Private Sector by : Donald Marron

Download or read book Prescription Drug Pricing in the Private Sector written by Donald Marron and published by CreateSpace. This book was released on 2012-02-20 with total page 34 pages. Available in PDF, EPUB and Kindle. Book excerpt: As prescription drugs move from manufacturers to consumers, a complex set of market transactions involving prices, discounts, and rebates occurs along the supply chain. Although the drugs themselves move in a relatively straightforward way, the flow of payments and the process by which they are determined are much more complex. This Congressional Budget Office (CBO) paper, prepared at the request of Senate Majority Leader Frist, explains the supply chain, the flow of payments, and the process by which payments are determined and provides estimates of the relative prices that retail pharmacies and nonretail providers pay for prescription drugs. In keeping with CBO's mandate to provide objective, nonpartisan analysis, this paper makes no recommendations. Julie Somers and Anna Cook prepared the paper under the supervision of Joseph Kile, David Moore, Bruce Vavrichek, and James Baumgardner. Alshadye Yemane and Susan Labovich assisted with the data analysis, and Peter Richmond assisted with the figures. Allison Percy served as CBO's internal reviewer. Information and data were provided by the Centers for Medicare & Medicaid Services as well as by IMS Health. Tom Bradley, Philip Ellis, Arlene Holen, Amy Petz, Shinobu Suzuki, and Tom Woodward provided useful comments on drafts. Outside of CBO, Terry Latanich and Judy Wagner, both private consultants, did the same. Includes a discussion of the supply chain, price measures, single-source brand-name drugs, and multiple-source drugs.

Prescription Drug Pricing in the Private Sector

Author :
Publisher :
ISBN 13 :
Total Pages : 26 pages
Book Rating : 4.:/5 (1 download)

DOWNLOAD NOW!

Book Synopsis Prescription Drug Pricing in the Private Sector by :

Download or read book Prescription Drug Pricing in the Private Sector written by and published by . This book was released on 2007 with total page 26 pages. Available in PDF, EPUB and Kindle. Book excerpt: The supply chain -- Pricing strategies and measures -- The roles of pharmacy benefit managers and pharmacies -- Single-source brand-name drugs -- Multiple-source drugs.

Prescription Drug Pricing: Background, Discount Programs and Cost Lowering Strategies

Author : Elias B. Toft
Publisher : Nova Snova
ISBN 13 : 9781536176681
Total Pages : 248 pages
Book Rating : 4.1/5 (766 download)

DOWNLOAD NOW!

Book Synopsis Prescription Drug Pricing: Background, Discount Programs and Cost Lowering Strategies by : Elias B. Toft

Download or read book Prescription Drug Pricing: Background, Discount Programs and Cost Lowering Strategies written by Elias B. Toft and published by Nova Snova. This book was released on 2020-03-13 with total page 248 pages. Available in PDF, EPUB and Kindle. Book excerpt: Chapter 1 examines the actions of drug companies in raising prescription drug prices in the United States, as well as the effects of these actions on the Federal and state budgets, and on American families. Chapter 2 addresses frequently asked questions about government and private-sector policies that affect drug prices and availability. Among the prescription drug topics covered are federally funded research and development, regulation of direct-to-consumer advertising, legal restrictions on reimportation, and federal price negotiation. The 340B Drug Pricing Program requires drug manufacturers to sell outpatient drugs at discounted prices to covered entitiesâeligible clinics, hospitals, and othersâin order to have their drugs covered by Medicaid. Covered entities are only allowed to provide 340B drugs to certain eligible patients. Chapter 3 reviews the Health Resources and Services Administration's (HRSA) oversight of the 340B Program to ensure compliance with program rules. In 2017, nearly 60% of U.S. adults aged 18â64 reported being prescribed medication in the past 12 months. Approximately 70% of prescription medications carry out-of-pocket costs. Strategies to reduce prescription drug costs at the individual level are discussed in chapters 4 and 5. Each year, Americans pay more for prescription drugs, and rising drug prices have a disproportionate impact on older Americans. Chapter 6 examines the history of rising drug prices for the brand-name drugs most commonly prescribed for seniors. Generic drugsâcopies of brand-name drugsâlead to significant cost savings. Before a generic drug can be marketed, FDA must approve the generic drug application. According to FDA, applications go through an average of three cycles of review before being approved, which may take years. Chapter 7 examines 1) the first review cycle approval rate of generic drug applications in recent years and factors that may have contributed to whether applications were approved; and 2) changes FDA has made to increase the first review cycle approval rate.

Making Medicines Affordable

Author : National Academies of Sciences, Engineering, and Medicine
Publisher : National Academies Press
ISBN 13 : 0309468086
Total Pages : 235 pages
Book Rating : 4.3/5 (94 download)

DOWNLOAD NOW!

Book Synopsis Making Medicines Affordable by : National Academies of Sciences, Engineering, and Medicine

Download or read book Making Medicines Affordable written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2018-03-01 with total page 235 pages. Available in PDF, EPUB and Kindle. Book excerpt: Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.

The Right Price

Author : Peter J. Neumann
Publisher : Oxford University Press
ISBN 13 : 0197512887
Total Pages : 273 pages
Book Rating : 4.1/5 (975 download)

DOWNLOAD NOW!

Book Synopsis The Right Price by : Peter J. Neumann

Download or read book The Right Price written by Peter J. Neumann and published by Oxford University Press. This book was released on 2021 with total page 273 pages. Available in PDF, EPUB and Kindle. Book excerpt: The prescription drug market -- Proposed solutions for rising drug prices -- Measuring the value of prescription drugs -- Measuring drug value : whose job is it anyway? -- Institute for Clinical and Economic Review (ICER) -- Other US value assessment frameworks -- Do drugs for special populations warrant higher prices? -- Improving value measurement -- Aligning prices with value -- The path forward.

The Role of NIH in Drug Development Innovation and Its Impact on Patient Access

Author : National Academies of Sciences, Engineering, and Medicine
Publisher : National Academies Press
ISBN 13 : 0309498511
Total Pages : 103 pages
Book Rating : 4.3/5 (94 download)

DOWNLOAD NOW!

Book Synopsis The Role of NIH in Drug Development Innovation and Its Impact on Patient Access by : National Academies of Sciences, Engineering, and Medicine

Download or read book The Role of NIH in Drug Development Innovation and Its Impact on Patient Access written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2020-01-27 with total page 103 pages. Available in PDF, EPUB and Kindle. Book excerpt: To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24â€"25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop.

Pharmaceutical Prices in the 21st Century

Author : Zaheer-Ud-Din Babar
Publisher : Springer
ISBN 13 : 3319121693
Total Pages : 410 pages
Book Rating : 4.3/5 (191 download)

DOWNLOAD NOW!

Book Synopsis Pharmaceutical Prices in the 21st Century by : Zaheer-Ud-Din Babar

Download or read book Pharmaceutical Prices in the 21st Century written by Zaheer-Ud-Din Babar and published by Springer. This book was released on 2014-12-05 with total page 410 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book provides an overview of the global pharmaceutical pricing policies. Medicines use is increasing globally with the increase in resistant microbes, emergence of new treatments, and because of awareness among consumers. This has resulted in increased drug expenditures globally. As the pharmaceutical market is expanding, a variety of pharmaceutical pricing strategies and policies have been employed by drug companies, state organizations and pharmaceutical pricing authorities.

The Impact of Private Sector Pricing Policy on Health Care

Author : You Wang
Publisher :
ISBN 13 :
Total Pages : 43 pages
Book Rating : 4.:/5 (864 download)

DOWNLOAD NOW!

Book Synopsis The Impact of Private Sector Pricing Policy on Health Care by : You Wang

Download or read book The Impact of Private Sector Pricing Policy on Health Care written by You Wang and published by . This book was released on 2013 with total page 43 pages. Available in PDF, EPUB and Kindle. Book excerpt: In 2006, Walmart launched a program that cut prices of nearly 300 generic prescription drugs to $4 per prescription for a month's supply. This is a nation-wide program and is available to people with or without insurance. My thesis research examines the impact of a private firm's pricing policy on health spending behavior, health utilization and health outcomes.

Prescription Drugs: An Overview of Approaches to Negotiate Drug Prices Used by Other Countries & U.S. Private Payers & Federal Programs

Author :
Publisher : DIANE Publishing
ISBN 13 : 9781422313602
Total Pages : 22 pages
Book Rating : 4.3/5 (136 download)

DOWNLOAD NOW!

Book Synopsis Prescription Drugs: An Overview of Approaches to Negotiate Drug Prices Used by Other Countries & U.S. Private Payers & Federal Programs by :

Download or read book Prescription Drugs: An Overview of Approaches to Negotiate Drug Prices Used by Other Countries & U.S. Private Payers & Federal Programs written by and published by DIANE Publishing. This book was released on with total page 22 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Prescription Drug Pricing and Negotiation

Author : United States. Congress. Senate. Committee on Finance
Publisher :
ISBN 13 :
Total Pages : 204 pages
Book Rating : 4.0/5 ( download)

DOWNLOAD NOW!

Book Synopsis Prescription Drug Pricing and Negotiation by : United States. Congress. Senate. Committee on Finance

Download or read book Prescription Drug Pricing and Negotiation written by United States. Congress. Senate. Committee on Finance and published by . This book was released on 2007 with total page 204 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Prescription Drug Pricing

Author : Sarah F. Jaggar
Publisher :
ISBN 13 :
Total Pages : 12 pages
Book Rating : 4.3/5 (91 download)

DOWNLOAD NOW!

Book Synopsis Prescription Drug Pricing by : Sarah F. Jaggar

Download or read book Prescription Drug Pricing written by Sarah F. Jaggar and published by . This book was released on 1996 with total page 12 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Generic drug entry prior to patent expiration an FTC study

Author :
Publisher : DIANE Publishing
ISBN 13 : 1428951938
Total Pages : 129 pages
Book Rating : 4.4/5 (289 download)

DOWNLOAD NOW!

Book Synopsis Generic drug entry prior to patent expiration an FTC study by :

Download or read book Generic drug entry prior to patent expiration an FTC study written by and published by DIANE Publishing. This book was released on 2002 with total page 129 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Pharmaceutical Economics and Policy

Author : Stuart O. Schweitzer
Publisher : Oxford University Press
ISBN 13 : 9780195300956
Total Pages : 362 pages
Book Rating : 4.3/5 (9 download)

DOWNLOAD NOW!

Book Synopsis Pharmaceutical Economics and Policy by : Stuart O. Schweitzer

Download or read book Pharmaceutical Economics and Policy written by Stuart O. Schweitzer and published by Oxford University Press. This book was released on 2007 with total page 362 pages. Available in PDF, EPUB and Kindle. Book excerpt: Publisher description

WHO guideline on country pharmaceutical pricing policies

Author :
Publisher : World Health Organization
ISBN 13 : 9240011870
Total Pages : 70 pages
Book Rating : 4.2/5 (4 download)

DOWNLOAD NOW!

Book Synopsis WHO guideline on country pharmaceutical pricing policies by :

Download or read book WHO guideline on country pharmaceutical pricing policies written by and published by World Health Organization. This book was released on 2020-09-29 with total page 70 pages. Available in PDF, EPUB and Kindle. Book excerpt: In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems' ability to provide population-wide access to essential medicines. Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products. This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.

Prescription Drugs: Oversight of Drug Pricing in Federal Programs

Author :
Publisher : DIANE Publishing
ISBN 13 : 9781422313558
Total Pages : 18 pages
Book Rating : 4.3/5 (135 download)

DOWNLOAD NOW!

Book Synopsis Prescription Drugs: Oversight of Drug Pricing in Federal Programs by :

Download or read book Prescription Drugs: Oversight of Drug Pricing in Federal Programs written by and published by DIANE Publishing. This book was released on 2007 with total page 18 pages. Available in PDF, EPUB and Kindle. Book excerpt:

How Increased Competition from Generic Drugs Has Affected Prices and Returns in the Pharmaceutical Industry

Author :
Publisher : U.S. Government Printing Office
ISBN 13 :
Total Pages : 94 pages
Book Rating : 4.:/5 (327 download)

DOWNLOAD NOW!

Book Synopsis How Increased Competition from Generic Drugs Has Affected Prices and Returns in the Pharmaceutical Industry by :

Download or read book How Increased Competition from Generic Drugs Has Affected Prices and Returns in the Pharmaceutical Industry written by and published by U.S. Government Printing Office. This book was released on 1998 with total page 94 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Handbook of Pharmaceutical Public Policy

Author : Thomas Fulda
Publisher : CRC Press
ISBN 13 : 9781439804261
Total Pages : 714 pages
Book Rating : 4.8/5 (42 download)

DOWNLOAD NOW!

Book Synopsis Handbook of Pharmaceutical Public Policy by : Thomas Fulda

Download or read book Handbook of Pharmaceutical Public Policy written by Thomas Fulda and published by CRC Press. This book was released on 2007-07-25 with total page 714 pages. Available in PDF, EPUB and Kindle. Book excerpt: Get an invaluable view of the impact of economics and politics on pharmaceuticals in the United States Pharmacy and pharmaceutical drug use are highly regulated and the various regulatory forces interact with diverse goals. Pharmaceutical Public Policy is a comprehensive review of the legislation, trends, business developments, and policy interpretations that have shaped drug use during the last 50 years. This unique single source explains drug regulatory activity, the major insurance and payment systems, and the impact of economics and politics on drug use in the United States. Leading experts provide a thorough and objective look at public policy issues, making this text perfect for upper level undergraduate and graduate level pharmacy, medical, and public health educators and students. Pharmacists and pharmacy students must learn more than just the physical sciences and clinical aspects of the pharmaceutical industry. The rationale for policies, rules, and regulations is integral to understanding how to best serve patients and make the entire pharmaceutical sector more equitable and cost-effective. Pharmaceutical Public Policy examines the most pressing issues facing the industry, including control of the rising costs for drugs and ensuring correct drug usage by patients. This insightful text offers an in depth perspective of the policies and the debates that surround them. Chapters are well-referenced and many include helpful figures and tables to illustrate facts and ideas. Topics in Pharmaceutical Public Policy include: pharmacy law and regulation Medicare and prescription drug coverage FDA drug approval process Medicaid and prescription drugs public health pharmacy Department of Veterans Affairs pharmacy programs Department of Defense pharmacy programs innovative state drug program practices state and federal regulation of pharmacy the future of the pharmaceutical industry managed care pharmacy PBM’s (pharmacy benefit managers) risk minimization importation and reimportation biotechnology and pharmacogenetics policy and issues product promotion competition between drugs drug insurance design patient compliance abuse of prescription drugs health care systems and insurance in Europe much more Pharmaceutical Public Policy is a one-of-a-kind resource that explains just who the players are and the complexity of the issues that are examined in most pharmaceutical policy debates, and is perfect for pharmacy students, educators, other health professionals, trade association leaders, and policymakers.